Holen Sie sich die Stockscreener-App
8.06
1.59%
-0.13
Handel nachbörslich:
8.06
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NEO?
Forum
Prognose
Aktiensplit
Finanzdaten der Neogenomics Inc-Aktie (NEO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
7.91%
181.33
|
168.03 | 172.00 | 167.82 | 164.50 |
| Cost Of Revenue |
9.79%
104.07
|
94.79 | 94.74 | 92.94 | 92.01 |
| Gross Profit |
5.48%
77.26
|
73.25 | 77.26 | 74.88 | 72.49 |
Operating Expenses
|
23.56%
124.89
|
101.07 | 95.66 | 96.08 | 94.44 |
| Benefits Costs and Expenses |
17.27%
227.15
|
193.69 | 188.13 | 185.67 | 183.52 |
| Costs And Expenses |
17.27%
227.15
|
193.69 | 188.13 | 185.67 | 183.52 |
| Operating Income/Loss |
71.17%
-47.63
|
-27.82 | -18.40 | -21.20 | -21.94 |
| Income/Loss From Continuing Operations Before Tax |
78.57%
-45.82
|
-25.66 | -16.13 | -17.85 | -19.02 |
| Income Tax Expense/Benefit |
372.18%
-0.724
|
0.266 | -0.804 | -0.15 | -0.375 |
| Income/Loss From Continuing Operations After Tax |
73.95%
-45.09
|
-25.92 | -15.32 | -17.70 | -18.64 |
|
Net Income/Loss
|
73.95%
-45.09
|
-25.92 | -15.32 | -17.70 | -18.64 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.45%
127.95
|
127.38 | 0.167 | 126.95 | 126.41 |
| Diluted Average Shares |
0.45%
127.95
|
127.38 | 0.167 | 126.95 | 126.41 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.32%
0.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):